Actively Recruiting
Evaluating the Vira Platform as a Digital Support for Opioid Use Disorder Treatment with Buprenorphine or Methadone
Led by Rhode Island Hospital · Updated on 2026-08-26
40
Participants Needed
1
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a digital mental health platform called the Vira Platform for people with Opioid Use Disorder OUD who are prescribed buprenorphine or methadone medication. The study aims to see if delivering behavioral activation through this app, supported by peer recovery specialists, can improve treatment engagement and retention compared to usual care. This trial focuses on helping patients stay connected to care and reducing the risks of overdose and death. Participants will be randomly assigned to either use the Vira Platform, which uses smartphone sensing to offer timely behavioral nudges and support from certified peer specialists, or receive standard outpatient buprenorphine or methadone treatment as usual. Behavioral activation is the main intervention delivered digitally through the app, while the control group continues with routine medication treatment. The study lasts at least three months with assessments at baseline and follow-up. During the study, participants will complete questionnaires and interviews to measure medication retention, treatment engagement, opioid use, cravings, mood, sleep, quality of life, social support, and safety at the start and after three months. The researchers will monitor these outcomes to evaluate the impact of the digital platform. Participants must have access to a personal smartphone and be fluent in English. The study is sponsored by Rhode Island Hospital and is scheduled to complete in early 2027.
CONDITIONS
Brief Title
Personalized Addiction Treatment enHancement
Research Team
S
Susan Ramsey, PhD
E
Evan Ames
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here